Haemonetics Corp. (NYSE:HAE) Stock is trading Higher 8.93% From 200-Day SMA
Mizuho raised the price target for the Haemonetics Corp. (NYSE:HAE) stock to “a Buy”. The rating was released on October 13, 2022, according to finviz. The research report from Citigroup has downgraded the stock from Buy to Neutral, with a price target set at $59. The stock was resumed by Raymond James, who disclosed in […]
initiated: Mizuho Recommends Haemonetics Corp. (NYSE:HAE) Stock to “a Buy”
Mizuho raised the price target for the Haemonetics Corp. (NYSE:HAE) stock to “a Buy”. The rating was released on October 13, 2022, according to finviz. The research report from Citigroup has downgraded the stock from Buy to Neutral, with a price target set at $59. The stock was resumed by Raymond James, who disclosed in […]
Why Haemonetics Corp. (NYSE:HAE) Stock declined -0.05% in Last Three Months?
Mizuho raised the price target for the Haemonetics Corp. (NYSE:HAE) stock to “a Buy”. The rating was released on October 13, 2022, according to finviz. The research report from Citigroup has downgraded the stock from Buy to Neutral, with a price target set at $59. The stock was resumed by Raymond James, who disclosed in […]
